Education
About Us
Working with TipRanks
Follow Us
Ventana Global Inc (VNTA)
:VNTA
VNTA Stock Chart & Stats
$0.04
>-$0.01(-72.22%)
At close: 4:00 PM EST
$0.04
>-$0.01(-72.22%)
Day’s Range― - ―
52-Week Range$0.01 - $0.12
Previous CloseN/A
Volume2.10K
Average Volume (3M)1.28K
Market Cap
$217.51K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)395.0
Beta-4.56
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding2,753,350
10 Day Avg. Volume3,798
30 Day Avg. Volume1,280
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
VNTA FAQ
What was Ventana Global Inc’s price range in the past 12 months?
Ventana Global Inc lowest stock price was $0.01 and its highest was $0.12 in the past 12 months.
What is Ventana Global Inc’s market cap?
Ventana Global Inc’s market cap is $217.51K.
When is Ventana Global Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Ventana Global Inc’s earnings last quarter?
Currently, no data Available
Is Ventana Global Inc overvalued?
According to Wall Street analysts Ventana Global Inc’s price is currently Overvalued.
Does Ventana Global Inc pay dividends?
Ventana Global Inc does not currently pay dividends.
What is Ventana Global Inc’s EPS estimate?
Ventana Global Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Ventana Global Inc have?
Ventana Global Inc has 2,753,350 shares outstanding.
What happened to Ventana Global Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Ventana Global Inc?
Currently, no hedge funds are holding shares in VNTA
Company Description
Ventana Global Inc
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. The company focuses in the areas of anti-obesity and related illnesses. The company holds rights for the formula for a medicament containing chewing gum with a composition of the extract of hoodia gordonii and 2-hydroxyoleic acid for the treatment of obesity, hypertension, and other metabolic disorders. The company develops appetite suppressant chewing gums, including the low dosage product for the over-the-counter market and the high dosage product for distribution by pharmacists. It intends to market low dosage product though drug and health food stores. The company was formerly known as Personalica, Inc. and changed its name to Ventana Biotech, Inc. in October 2008. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland.
Technical Analysis
Israel Acquisitions Corp. Class A
―
Ares Acquisition Corporation II Class A
―
Agriculture & Natural Solutions Acquisition Corporation Class A
―
GrabAGun Digital Holdings
―
Legato Merger Corp. III
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.02% Other Institutional Investors
99.98% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---